ArticleClinical cancer research : an official journal of the American Association for Cancer Research2019

Retooling a Blood-Based Biomarker: Phase I Assessment of the High-Affinity CA19-9 Antibody HuMab-5B1 for Immuno-PET Imaging of Pancreatic Cancer.

Christian Lohrmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.